Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Executive-branch trades in RPRX

Executive-branch disclosures

The executive-branch officials on file who disclosed a trade in RPRX, newest first. Every disclosed trade on file for this name — not a window.

RPRX · Royalty Pharma plcHealth Carelatest OGE posting 2026-08-13

Trades in RPRX· as disclosed

3 officials · 4 disclosed rows · 0P/4S · both branches →
OfficialAssetTypeAmountTrade dateFiledTrade → posted
Donald J TrumpTrumpPresident of the United States of AmericaRPRXROYALTY PHARMA PLC CL ASALE$1,001–$15,0002026-04-0730d+2026-06-2585d
Donald J TrumpTrumpPresident of the United States of AmericaRPRXROYALTY PHARMA PLC CL ASALE$1,001–$15,0002026-02-1930d+2026-05-0884d
Christopher LandauLandauDeputy Secretary of StateRPRXRoyalty Pharma plc Class A Ordinary Shares (RPRX)SALE$100,001–$250,0002025-04-282025-05-2279d
Stacey DixonDixonPrincipal Deputy Director of National IntelligenceRPRXROYALTY PHARMA PLC SHS CLASS A (RPRX)noteSALE$1,001–$15,0002021-08-232021-08-248d

30d+ — the filer reported being notified more than 30 days after the trade.

1,948 of the 7,869 rows these officials filed are unmapped text — no ticker, so no ticker list can reach them.

The officials OGE posts for direct download. Rows whose asset is filed as words with no resolvable ticker cannot appear — their absence is not an absence of activity. OGE Forms 278-T & 278e · amounts are RANGES · as disclosed, no causal claim.

Stocks the executive branch trades most · trailing 180 daysExecutive-branch disclosures